Anti-ulcer agent
class of drugs used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract
Anti-ulcer agents are medications or supplements used to cure the damage of mucosal layer on organs to prevent the damage from further extending to deeper regions to cause complications.
An anti-ulcer medication for treating mouth ulcer is triamcinolone, a corticosteroid. Other anti-ulcer supplements include vitamin B2 and vitamin B12.
Antibiotics and agents to reduce gastric acid secretion are used in combinations to treat Helicobacter pylori (H. pylori)-induced peptic ulcer disease (PUD), an ulceration in the gastric region. Antibiotics include amoxicillin, clarithromycin and metronidazole. Bismuth subsalicylate is an antimicrobial agent of another drug class that can also be used to eradicate H. pylori for treating PUD. Agents for suppressing gastric acid secretion are proton-pump inhibitors (PPI), such as lansoprazole, pantoprazole, rabeprazole, omeprazole and esomeprazole.
Anti-ulcer agents to treat mouth ulcer
Triamcinolone, vitamin B2 and vitamin B12 can be used to treat mouth ulcers, which are confined, shallow, round to oval-shaped lesions that sometimes contain yellowish adherent central exudate and give a pain sensation.
Triamcinolone
Triamcinolone is a corticosteroid, which can be applied on the ulcerated region to cure mouth ulcer by its anti-inflammatory action.
Medical uses and available forms
Triamcinolone is mainly used to treat recurrent mild to moderate aphthous stomatitis, also known as mouth ulcer. This medication should show anti-ulcer effect or repair of oral tissues in seven days.
The public source identifies “Anti-ulcer agent” as class of drugs used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. This brief keeps that definition visible, then builds a research path around Anti-ulcer, agent and class.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Anti-ulcer agent”, the useful work is to connect “class of drugs used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Oct 6, 2025. The linked authority identifier is Q41602594. None of the 0 selected statements returned an explicit reference.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Anti-ulcer agent”, its source revision and the description used here.
- Expand the search: follow Anti-ulcer agent primary sources, Anti-ulcer agent archive and Anti-ulcer research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Anti-ulcer agent”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Anti-ulcer agent” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.